Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02832115

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Aultman Health Foundation (from the registry)
Registry
  • NCT NCT02832115
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02832115. Randomized; double masking; primary purpose prevention. Start 2016-09 (actual); primary completion 2019-05-02 (actual). Results posted on 2020-10-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
Acronym
TNT-RASP
Condition
Radial Artery Spasm
Condition
Angina
Intervention (Drug)
Topical Nitroglycerine
Intervention (Drug)
Topical Lidocaine
Lead sponsor
Aultman Health Foundation (class: other)

Record details

Record id
cardio:ct-nct02832115
Content hash
785c5ece5d32e0618223c2039bbba188a91202bb7260b6b3ed76e6d5a07657b2